Citigroup »

Recursion Pharmaceuticals shares owned by Citigroup

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.0M 405k 9.86
2023-09-30 $3.6M 471k 7.65
2023-03-31 $4.6M 688k 6.67
2022-12-31 $1.8M 233k 7.71
2022-09-30 $1.7M 162k 10.64
2021-12-31 $4.2M 244k 17.13